Published in Bioconjug Chem on November 12, 2010
Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma. J Med Chem (2013) 0.97
Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide. Bioconjug Chem (2012) 0.88
Theranostics of malignant melanoma with 64CuCl2. J Nucl Med (2014) 0.87
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer. Eur J Nucl Med Mol Imaging (2012) 0.85
Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry. Bioorg Med Chem Lett (2011) 0.82
A novel aliphatic 18F-labeled probe for PET imaging of melanoma. Mol Pharm (2013) 0.81
Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma. Biomed Res Int (2014) 0.77
Preclinical Melanoma Imaging with (68)Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET. Theranostics (2017) 0.75
PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging (2017) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Melanoma biology and new targeted therapy. Nature (2007) 10.71
Clinical applications of PET in oncology. Radiology (2004) 3.44
[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjug Chem (2004) 2.20
Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells. Cancer Res (1989) 2.03
Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res (2006) 1.96
18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression. Mol Imaging Biol (2009) 1.90
Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug Chem (2009) 1.88
64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression. Bioconjug Chem (2007) 1.79
Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues. Cancer Res (2000) 1.73
Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med (2006) 1.69
Peptides and peptide hormones for molecular imaging and disease diagnosis. Chem Rev (2010) 1.63
A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis. J Nucl Med (2002) 1.57
Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH. J Med Chem (2005) 1.49
Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol (2006) 1.41
Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination. Proc Natl Acad Sci U S A (1998) 1.39
Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties. J Nucl Med (2001) 1.33
Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake. J Nucl Med (2005) 1.31
Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues. J Med Chem (2002) 1.21
Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog. J Nucl Med (2007) 1.16
Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma. Cancer Res (2004) 1.04
Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res (1994) 1.01
PET of malignant melanoma using 18F-labeled metallopeptides. J Nucl Med (2009) 0.93
Peptide-targeted radionuclide therapy for melanoma. Crit Rev Oncol Hematol (2008) 0.93
Molecular probes for malignant melanoma imaging. Curr Pharm Biotechnol (2010) 0.91
Models and mechanisms in malignant melanoma. Mol Carcinog (2007) 0.90
Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy. Methods Mol Biol (2007) 0.81
Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol (2008) 6.41
microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. J Nucl Med (2005) 2.96
microPET-based biodistribution of quantum dots in living mice. J Nucl Med (2007) 2.76
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small (2009) 2.59
Molecular optical imaging with radioactive probes. PLoS One (2010) 2.36
Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology (2008) 1.88
Radiation-luminescence-excited quantum dots for in vivo multiplexed optical imaging. Small (2010) 1.87
Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett (2008) 1.85
Pulmonary Lophomonas blattarum infection in patients with kidney allograft transplantation. Transpl Int (2006) 1.85
Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy. Eur J Nucl Med Mol Imaging (2010) 1.75
Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor. Small (2011) 1.46
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano (2010) 1.46
De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection. Kidney Int (2010) 1.45
Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton) (2012) 1.45
Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging. J Nucl Med (2011) 1.43
Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT. Radiology (2014) 1.43
Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. Small (2010) 1.38
Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res (2009) 1.38
One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging (2011) 1.34
In vitro and in vivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. Angew Chem Int Ed Engl (2012) 1.33
Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study. J Nucl Med (2012) 1.30
Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med (2010) 1.28
In vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.26
Synthesis and radioluminescence of PEGylated Eu(3+) -doped nanophosphors as bioimaging probes. Adv Mater (2011) 1.26
In vivo tumor-targeted fluorescence imaging using near-infrared non-cadmium quantum dots. Bioconjug Chem (2010) 1.24
Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein. Bioconjug Chem (2010) 1.24
Preclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imaging. Small (2011) 1.21
Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice. J Nucl Med (2005) 1.20
A novel method for direct site-specific radiolabeling of peptides using [18F]FDG. Bioconjug Chem (2009) 1.11
Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. Biomaterials (2010) 1.11
Construction and validation of nano gold tripods for molecular imaging of living subjects. J Am Chem Soc (2014) 1.10
Tyrosinase as a multifunctional reporter gene for Photoacoustic/MRI/PET triple modality molecular imaging. Sci Rep (2013) 1.10
64Cu-labeled affibody molecules for imaging of HER2 expressing tumors. Mol Imaging Biol (2009) 1.10
A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression. J Nucl Med (2009) 1.09
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging. Chem Commun (Camb) (2010) 1.08
Direct site-specific radiolabeling of an Affibody protein with 4-[18F]fluorobenzaldehyde via oxime chemistry. Mol Imaging Biol (2008) 1.08
Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors. J Biomed Opt (2010) 1.07
A metal-based inhibitor of tumor necrosis factor-α. Angew Chem Int Ed Engl (2012) 1.06
Dynamic visualization of RGD-quantum dot binding to tumor neovasculature and extravasation in multiple living mouse models using intravital microscopy. Small (2010) 1.05
Endoscopic imaging of Cerenkov luminescence. Biomed Opt Express (2012) 1.05
Protein scaffold-based molecular probes for cancer molecular imaging. Amino Acids (2010) 1.05
Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem (2007) 1.05
Impact of a multiple mice holder on quantitation of high-throughput MicroPET imaging with and without Ct attenuation correction. Mol Imaging Biol (2013) 1.05
Optical imaging of reporter gene expression using a positron-emission-tomography probe. J Biomed Opt (2011) 1.04
Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway. PLoS One (2013) 1.03
Protein-protein interactions and membrane localization of the human organic solute transporter. Am J Physiol Gastrointest Liver Physiol (2007) 1.03
Melanin-targeted preclinical PET imaging of melanoma metastasis. J Nucl Med (2009) 1.02
Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc (2014) 1.01
Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1. Eur J Neurosci (2008) 1.00
A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects. Bioconjug Chem (2010) 1.00
Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med (2006) 0.99
A novel clinically translatable fluorescent nanoparticle for targeted molecular imaging of tumors in living subjects. Nano Lett (2011) 0.99
Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials (2013) 0.99
An engineered knottin peptide labeled with 18F for PET imaging of integrin expression. Bioconjug Chem (2009) 0.98
Perylene-diimide-based nanoparticles as highly efficient photoacoustic agents for deep brain tumor imaging in living mice. Adv Mater (2014) 0.98
Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe. PLoS One (2011) 0.97
Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma. J Med Chem (2013) 0.97
Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria. Clin Cancer Res (2009) 0.95
18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6. J Nucl Med (2013) 0.94
Strained cyclooctyne as a molecular platform for construction of multimodal imaging probes. Angew Chem Int Ed Engl (2015) 0.93
PET of malignant melanoma using 18F-labeled metallopeptides. J Nucl Med (2009) 0.93
Reproducibility study of [(18)F]FPP(RGD)2 uptake in murine models of human tumor xenografts. Eur J Nucl Med Mol Imaging (2010) 0.93
Engineered two-helix small proteins for molecular recognition. Chembiochem (2009) 0.93
PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides. Theranostics (2011) 0.92
PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide. Cancer Res (2010) 0.92
Near-infrared quantum dots as optical probes for tumor imaging. Curr Top Med Chem (2010) 0.92
Molecular probes for malignant melanoma imaging. Curr Pharm Biotechnol (2010) 0.91
In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene. Mol Imaging Biol (2007) 0.91
Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha. Bioconjug Chem (2012) 0.91